These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 16549141

  • 1. Outcome of kidney transplantation for renal amyloidosis:a single-center experience.
    Celik A, Saglam F, Dolek D, Sifil A, Soylu A, Cavdar C, Temizkan A, Bora S, Gulay H, Camsari T.
    Transplant Proc; 2006 Mar; 38(2):435-9. PubMed ID: 16549141
    [Abstract] [Full Text] [Related]

  • 2. Transplantation in renal amyloidosis.
    Türkmen A, Yildiz A, Erkoç R, Ecder T, Görçin B, Türk S, Aydin AE, Eldegez U, Ark E, Sever MS.
    Clin Transplant; 1998 Oct; 12(5):375-8. PubMed ID: 9787944
    [Abstract] [Full Text] [Related]

  • 3. Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases.
    Jacob ET, Bar-Nathan N, Shapira Z, Gafni J.
    Arch Intern Med; 1979 Oct; 139(10):1135-8. PubMed ID: 384952
    [Abstract] [Full Text] [Related]

  • 4. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D, Chen JH, Wu WZ, Yang SL, Wu GJ, Wang H, Tan JM.
    Transplant Proc; 2007 Oct; 39(1):69-72. PubMed ID: 17275476
    [Abstract] [Full Text] [Related]

  • 5. Among therapy modalities of end-stage renal disease, renal transplantation improves survival in patients with amyloidosis.
    Ozdemir BH, Ozdemir FN, Sezer S, Sar A, Haberal M.
    Transplant Proc; 2006 Mar; 38(2):432-4. PubMed ID: 16549140
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.
    Keven K, Sengul S, Kutlay S, Ekmekci Y, Anadol E, Nergizoglu G, Ates K, Erturk S, Erbay B.
    Transplant Proc; 2004 Nov; 36(9):2632-4. PubMed ID: 15621109
    [Abstract] [Full Text] [Related]

  • 7. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center.
    Gutierrez-Baños J, Portillo J, Ballestero R, Zubillaga S, Ramos E, Campos J, Hidalgo E.
    Transplant Proc; 2008 Dec; 40(10):3424-7. PubMed ID: 19100404
    [Abstract] [Full Text] [Related]

  • 8. Complications of renal transplantation in patients with amyloidosis.
    Haq A, Hussain S, Meskat B, Mohan P, Conlon P, Hickey DP.
    Transplant Proc; 2007 Dec; 39(1):120-4. PubMed ID: 17275487
    [Abstract] [Full Text] [Related]

  • 9. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M, Immunopathology Group of the Italian Society of Nephrology.
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [Abstract] [Full Text] [Related]

  • 10. Combined liver-kidney transplantation--S. Orsola experience: nephrological aspects.
    Mosconi G, Scolari MP, Feliciangeli G, D'Arcangelo GL, Buscaroli A, D'Addio F, Conte D, Faenza A, Pinna AD, Stefoni S.
    Transplant Proc; 2006 May; 38(4):1122-4. PubMed ID: 16757283
    [Abstract] [Full Text] [Related]

  • 11. Renal transplantation in secondary systemic amyloidosis.
    Heering P, Hetzel R, Grabensee B, Opelz G.
    Clin Transplant; 1998 Jun; 12(3):159-64. PubMed ID: 9642504
    [Abstract] [Full Text] [Related]

  • 12. Effect of amyloidosis on long-term survival in kidney transplantation.
    Emiroglu R, Başaran O, Pehlivan S, Ozdemir FN, Colak T, Moray G, Noyan T, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):2967-8. PubMed ID: 16213276
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of live donor kidney transplantation for renal amyloidosis.
    Sherif AM, Refaie AF, Sobh MA, Mohamed NA, Sheashaa HA, Ghoneim MA.
    Am J Kidney Dis; 2003 Aug; 42(2):370-5. PubMed ID: 12900821
    [Abstract] [Full Text] [Related]

  • 14. A third renal transplantation: is it relevant and is it worth it?
    Reboux AH, Kamar N, Fort M, Rischmann P, Malavaud B, Cointault O, Abbal M, Durand D, Rostaing L.
    Transplant Proc; 2005 Dec; 37(10):4199-202. PubMed ID: 16387077
    [Abstract] [Full Text] [Related]

  • 15. Long-term analysis of combined liver and kidney transplantation at a single center.
    Ruiz R, Kunitake H, Wilkinson AH, Danovitch GM, Farmer DG, Ghobrial RM, Yersiz H, Hiatt JR, Busuttil RW.
    Arch Surg; 2006 Aug; 141(8):735-41; discussion 741-2. PubMed ID: 16924080
    [Abstract] [Full Text] [Related]

  • 16. Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience.
    Hardinger KL, Schnitzler MA, Koch MJ, Labile E, Stirnemann PM, Miller B, Enkvetchakul D, Brennan DC.
    Transplantation; 2006 May 15; 81(9):1285-9. PubMed ID: 16699456
    [Abstract] [Full Text] [Related]

  • 17. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N, Rodger RS, McMillan MA, Junor BJ.
    Transplantation; 2007 Mar 15; 83(5):582-7. PubMed ID: 17353778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Mar 15; 38(2):499-501. PubMed ID: 16549159
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.